Published on Tuesday February 02, 2021

Smooth Drug Development January 2021 News Release

We are happy to present our new signed projects:

  • Contract for CTA submission of the final report with a new Sponsor.
  • Agreement for a bioequivalence study (INN: Dutasteride + Tamsulosin).


Clinical and Scientific Departments News:  

  • All initiation visits were performed in the phase III Acetylcysteine trial.
  • Initiation visits were performed in a III phase trial with Nimesulide, gel.
  • Clinical study report in Paracetamol bioequivalence trial was sent to the Sponsor.
  • We performed initiation visits in 2 sites in trial with Ethylmethylhydroxypyridine succinate